Intestinal dendritic cells (DCs) have been shown to display specialized functions, including the ability to promote gut tropism to lymphocytes, to polarize noninflammatory responses, and to drive the differentiation of adaptive Foxp3 + regulatory T (T reg ) cells. However, very little is known about what drives the mucosal phenotype of DCs. Here, we present evidence that the local microenvironment, and in particular intestinal epithelial cells (ECs), drive the differentiation of T reg -cell-promoting DCs, which counteracts Th1 and Th17 development. EC-derived transforming growth factor-(TGF-) and retinoic acid (RA), but not thymic stromal lymphopoietin (TSLP), were found to be required for DC conversion. After EC contact, DCs upregulated CD103 and acquired a tolerogenic phenotype. EC-conditioned DCs were capable of inducing de novo T reg cells with gut-homing properties that when adoptively transferred, protected mice from experimental colitis. Thus, we have uncovered an essential mechanism in which EC control of DC function is required for tolerance induction.
INTRODUCTION
The symbiosis between commensal bacteria and the gut has risks and benefits for the host organism because bacteria continuously challenge the fine balance of intestinal immune homeostasis with their cargo of microbial-associated molecular patterns (MAMPs). By binding to pattern recognition receptors, including Toll-like receptors, MAMPs can activate immune cells and lead to inflammation. 1, 2 The polarized expression of pattern recognition receptors on the basolateral membrane (or intracellularly) in epithelial cells (ECs) can limit their activation. 3 However, dendritic cells (DCs) that can intercalate between ECs for direct bacterial uptake 4 -6 could be continuously exposed to MAMP-dependent activation. If not held in check, the development of an exaggerated inflammatory response could lead to chronic inflammation and immune disorders such as inflammatory bowel disease and cancer. Unlike other tissues, lamina propria (LP) derived DCs (LP-DCs) have been shown to be less prone to the development of inflammatory responses. 7, 8 Gutderived CD103 + mesenteric lymph node (MLN) DCs (MLNDCs) and LP-DCs have been recently described to actively participate in the de novo generation of CD4 + CD25 + Foxp3 + regulatory T (T reg ) cells by a retinoic acid (RA)-and TGF--dependent mechanism. 9, 10 This suggests that either a subset of DCs or the local gut microenvironment plays a major role in controlling the activity of DCs, the development of inflammatory reactions, and the induction of tolerance. Interestingly, only the CD103 + population of LP-DCs or MLN-DCs is endowed with tolerogenic properties. As ECs express E-cadherin, 11 which is the ligand of CD103, we hypothesized that during the interaction of DCs with ECs, EC-derived factors could participate in driving the tolerogenic mucosal phenotype of gut DCs. Such a mechanism would guarantee that DCs that are in close contact with ECs could be less responsive to MAMP stimulation and might promote the development of adaptive T reg cells. Indeed, we show here that ECs induced the expression of CD103 on DCs and conferred upon them a mucosal phenotype through the action of RA and TGF-. EC-conditioned DCs (EC-DCs) drove the differentiation of gut-homing T reg cells that were protective against experimental colitis. Thus, we have discovered that ECs are not only a barrier between the external and internal world but also play an active role in controlling DC function and intestinal tolerance.
Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning
It has been recently shown that DCs of gut origin have the ability to convert naive T cells into Foxp3 + T reg cells. 9, 10 However, the mechanism of conferring tolerogenic properties upon gut DCs is still unknown. We reasoned that because of their close interaction with ECs, the ECs could participate in conferring the tolerogenic phenotype upon DCs. To evaluate whether DCs " educated " by ECs were able to promote T reg -cell differentiation, bone marrow-derived DCs (BMDCs) were incubated for 24 h with supernatant derived from a murine epithelial cell line (MODE-K). Conditioned DCs were pulsed for 6 h with ovalbumin (OVA), washed, and co-incubated with naive CD4 + CD25 − T cells from OVA-specific OT-II mice for 5 days. We then analyzed the development of CD4 + CD25 + Foxp3 + T reg cells by flow cytometry. Conditioning with MODE-K supernatant in the presence of OVA favored T reg -cell conversion (5.5 vs. 9.3 % , Figure 1a , c, and d), and this effect was enhanced by the presence of TGFduring the last 2 days of coculture (13.7 vs. 20.1 % , Figure 1a , c and d ). In addition, the capacity of EC-DCs to induce T reg -cell differentiation was tested using enhanced green fluorescent proteins (eGFP) − T cells isolated from Foxp3-eGFP reporter mice (Foxp3-GFP). Again, EC-DCs induced a higher rate of conversion of eGFP-Foxp3 − into eGFP-Foxp3 + T cells than non-conditioned DCs ( Supplementary Figure 1a, c and d ) .
To follow T-cell proliferation in culture, highly purified CD4 + CD25 − T cells were stained with carboxyfluorescein succinimidyl ester (CFSE) before incubation with DCs. At 3 days later, T cells were stained for Foxp3 expression and analyzed for CFSE dilution. EC-DCs induced the development of a higher number of proliferating Foxp3 + cells, whereas the number of proliferating Foxp3 − cells was similar in the two conditions ( Figure 1b ). The increase of T reg cells is likely because of their de novo differentiation rather than because of the expansion of already existing Foxp3 + cells, as the CD4 + CD25 − OTII cells used in the experiment expressed negligible levels of Foxp3 (from 0.3 to 0.5 % , Figure 1a ) . The experiments were then repeated using T cells isolated from DO11.10 SCID mice that have only naive T cells that do not express Foxp3. 9 BMDCs were derived from BALB / c mice, conditioned with EC supernatants and loaded with OVA as described above. Again, MODE-K-conditioned DCs displayed a greater ability to induce T reg -cell conversion than do control DCs ( Supplementary Figure 1b ) .
We then compared the ability of EC-DCs with that of nonconditioned BMDCs to influence the development of inflammatory CD4 + T cells. T cells incubated with EC-DCs produced lower amounts of interferon-(IFN-) and interleukin (IL)-17 in response to OVA than those incubated with non-conditioned DCs ( Figure 1e ). Confirming our previous observations that EC conditioning of human DCs also skewed toward a Th2 phenotype, 12 we observed an increase in IL-10, IL-13 and IL-5 levels in culture supernatants ( Supplementary Figure 2 ) . We were only able to detect low amounts of IL-5, IL-10, and IL-13 released by T cells, but we have to point out that this was a primary culture; whether these tiny amounts of ILs can exert a biological effect remains to be established, particularly in light of the still relevant Th1 and Th17 cytokines. These results indicate that EC-derived factors " educate " tolerogenic DCs to induce T reg -cell differentiation and concomitantly limit Th1 and Th17 inflammatory responses.
Next, we compared the suppressor activity of CD25 + T reg cells generated by EC-DCs and by non-conditioned DCs with that of CD25 + cells isolated from the mouse spleen. CD25 + T cells were isolated from conditioned or non-conditioned DC / T-cell cultures, or from the spleen, and incubated in a second proliferating antigen presentation assay using lipopolysaccharide (LPS)-matured DCs and CFSE-labeled CD4 + T cells in the presence of plate-bound -CD3. We found that CD25 + T reg cells generated by EC-DCs were more suppressive than non-conditioned DCgenerated or splenic CD25 + T reg cells ( Figure 1f ) .
Collectively, our results indicate that ECs can induce tolerogenic DCs and suggest the de novo development of functionally active T reg cells. This activity was observed when using conditioned BMDCs from both C57 / BL6J and BALB / c mice, suggesting a general rather than a background-restricted phenomenon.
EC-DCs are noninflammatory
As EC-DCs showed a reduced ability to drive Th1 and Th17 differentiation, we investigated the pattern of cytokines released by EC-DCs. We incubated BMDCs with supernatant from MODE-K cells and stimulated them with LPS (1 g ml − 1 ) for 6 h. We observed that, consistent with their ability to induce T reg -cell differentiation, EC-DCs produced significantly more IL-10 and IL-2, and less IL-12p70 in comparison with non-conditioned DCs ( Figure 2a ). In addition, together with the augmented production of cytokines involved in T reg -cell homeostasis, EC-DCs expressed lower amounts of mRNA coding for inflammatory cytokines involved in the polarization of Th1 (IL-12p35 coded by Il12a ) and Th17 (IL-23p19 coded by Il23a ) cells ( Figure 2b ). Hence, EC-DCs display limited production of inflammatory cytokines and drive T reg -cell differentiation.
Spleen DCs acquire mucosal DC properties and induce T reg -cell differentiation after " education " by ECs LP and MLNs have been reported to be the sites of peripheral T reg -cell generation, and DCs isolated from these tissues play a major role in this process. 9,10 Accordingly, we found that MLNDCs were able to induce the development of T reg cells (8.9 % ) with considerably higher efficiency compared with spleen DCs (3.2 % ) ( Figure 3a ). However, if splenic DCs were first incubated with MODE-K supernatant, the frequency of T reg cells in the cocultures was dramatically increased (9.1 % ) ( Figure 3a and b ). These data indicate that MLN-DCs display a superior ability to drive T reg -cell differentiation when compared with spleen DCs, a feature that is likely acquired in the periphery after EC conditioning, suggesting that " mucosal " DCs become so only after environmental education.
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The supernatant from intestinal ECs drives the development of T reg cells
To exclude the possibility that the observed ability of ECs to drive tolerogenic DCs could be due to the use of spent culture medium, which could nonspecifically inhibit DC maturation, we compared the supernatant of MODE-K cells with that of either a mouse mammary tumor epithelial cell line (4T1) or a highly proliferating fibroblast cell line (NIH-3T3) for their ability to drive tolerogenic DCs. As shown in Figure 4a and b , only DCs incubated with MODE-K cell supernatant were able to significantly increase the frequency of T reg cells in culture. It has been shown that gut DCs drive the development of T reg cells by a mechanism that is dependent on TGF-and RA. 9,10 Thus, we evaluated whether TGF-and aldh1a2 , an enzyme involved in the conversion of retinal into RA, were expressed by ECs. We also wanted to assess whether differences in the expression of these molecules could explain the diverse abilities of the tested cell lines to induce tolerogenic DCs. We found that only MODE-K cells expressed both aldh1a2 and TGF-, whereas 4T1 and 
NIH-3T3 cells expressed only TGF-( Figure 4c
)
EC-derived TGF-and RA induce tolerogenic DCs
As we have shown that MODE-K cells expressed TGF-and an enzyme involved in RA synthesis, we analyzed whether TGFand RA played any role in driving tolerogenic DCs, which would be able to induce T reg -cell development. Thus, BMDCs were incubated with MODE-K supernatant, with or without antibody neutralization of TGF-, before T-cell activation. Indeed, neutralization of TGF-in the MODE-K supernatant Figure 5c ). This was not due to unspecific effects of the neutralizing antibody because an isotype control had no effect on T reg -cell development ( Figure 5a and b ) . We then tested whether EC-derived RA was also required for the differentiation of tolerogenic DCs. DCs were incubated with an RA receptor inhibitor (LE540) for 1 h 
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before conditioning. At 24 h later, DCs were washed and incubated with naive OTII T cells, as above. We found that inhibition of RA signaling to DCs affected the induction of T reg cells ( Figure 5d and e ) and restored the development of Th17 responses ( Figure 5f ). However, we could not detect any synergistic effect in the inhibition of T reg -cell differentiation by blocking both TGF-and RA (data not shown). RA is likely derived from ECs in our experimental setting, as we found no increase in aldh1a2 expression in EC-DCs as compared with DCs alone, whereas intestinal ECs displayed a nearly three times higher expression of the enzyme than DCs ( Figure 5g ). On the other hand, aldh1a2 was highly expressed in colon tissue and MLN than in the spleen ( Figure 5g ). In particular, the CD103 + DC subset isolated from MLN showed the highest expression of aldh1a2 ( Figure 5g ), suggesting that DC-derived RA may also participate in T reg conversion at mucosal sites in vivo . Similar to what we already described in humans, 12 we found that MODE-K cells and primary murine ECs constitutively expressed TSLP ( Supplementary Figure 4 ) . Thus, we compared the ability of DCs isolated from MLN-or BM-DCs from TSLPR − / − mice to induce T reg -cell differentiation. The functional receptor for TSLP comprises two chains: IL7R chain, which is shared with IL-7 receptor, and a TSLP receptor chain (TSLPR). 13 Our results show that both TSLPR − / − and WT DCs ( Figure 6a and b ) had a similar ability to convert naive T cells into T reg cells, both before and after EC conditioning. All together, these results suggest that EC-derived TGF-and RA are needed for the promotion of the tolerogenic phenotype of DCs in mice, but TSLP could be dispensable.
EC contact drives CD103 expression on DCs that become tolerogenic
As DCs interact closely with ECs in the gut, we evaluated whether the proximity to ECs had differentially effected DC conditioning. Hence, we opted for the mouse CMT93 epithelial cell line that, unlike MODE-K cells, is able to form EC monolayers. CMT93 cells were grown on a transwell and murine BMDCs were added to the basolateral side of the EC monolayer. We measured the ability of DCs conditioned by CMT93 supernatant or direct CMT93 contact to drive the development of T reg cells. We found that in agreement with MODE-K cells, CMT93 supernatants were capable of driving the differentiation of tolerogenic DCs, but EC contact did not confer further differentiation ( Figure 7b and e ). As it has been shown that murine intestinal CD103 + DCs are able to convert naive T cells into Foxp3 + T reg cells 9 and are required for T-cell-mediated prevention of experimental colitis, 14 we asked whether EC contact could induce CD103 expression on BMDCs. Interestingly, CD103 was strongly upregulated on BMDCs after 24 h of direct contact with ECs ( Figure 7a and d ) . DCs incubated with EC supernatants were also able to upregulate CD103, but to a lower extent ( Figure 7a and d ) . When -TGF-(10 or 50 g ml − 1 ) or LE540 (1 or 10 n M ) were added to the EC-DC cocultures, we could not inhibit CD103 upregulation (data not shown). We then analyzed whether CD103 + and CD103 − cells obtained after contact with ECs had different abilities to drive T reg cells. As shown in Figure 7c -e , FACS (fluorescence-activated cell sorting)-sorted CD103 + cells showed a more than fourfold greater ability to drive T reg -cell development than did CD103 − DCs. This correlated with the ability of CD103 + but not CD103 − DCs to induce the expression of 4 7, an integrin involved in the homing of lymphocytes to the gut, on Foxp3 + cells and with a reduced production of IFN-and IL-17 ( Figure 7f and g ) . Interestingly, the contact with ECs induced the expression of aldh1a2 in DCs to a similar level as RA ( Figure 7h ). Together, these results suggest that EC contact by DCs promotes a full CD103 + DC mucosal tolerogenic phenotype. 
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EC-DC-induced T reg cells are protective in vivo against experimental colitis
We showed that EC-DCs acquired the ability to drive T reg -cell differentiation. Thus, we asked whether these newly generated T reg cells might have a protective function in vivo in the gut. T reg cell-enriched populations were generated using either BMDCs conditioned or unconditioned for 24 h with MODE-K supernatants after culture with CD4 + CD25 − T cells from the same mice. After 5 days of coculture, the frequency of CD4 + CD25 + Foxp3 + T reg cells in the two conditions was analyzed by FACS ( Figure  8a ). As we found that EC-DCs induce twice as many T reg cells, we wondered whether their frequency could be functionally significant and have an impact on the development of colitis. Thus we injected intravenous 1 × 10 6 total T cells ( Figure 8 ) or purified CD25 + T cells ( Supplementary Figure 5 ) -or PBS (phosphate buffered saline) as a control -into C57 / BL6J mice 8 h before colitis induction with 2 % (w / v) dextran sulfate sodium (DSS). The onset of DSS colitis was characterized by weight loss in all groups. Interestingly, mice adoptively transferred with total or purified CD25 + T cells generated using EC-DCs experienced reduced weight loss and a faster recovery as compared with the other two groups ( Figure 8b and Supplementary Figure 5 ). Twelve days from the beginning of DSS administration, mice receiving PBS or T cells generated with non-conditioned DCs still displayed signs of robust colitis, including swollen colons, contracted ceca, and watery stools ( Figure 8c ). Histopathological analysis confirmed that mice with gross alterations in intestinal appearance also displayed altered histology, including focal crypt epithelial destruction and extensive areas of epithelial hyperplasia associated with mononuclear infiltrates ( Figure  8d ). Consistent with the histology, mice receiving PBS or T cells generated with non-conditioned DCs displayed significantly increased amounts of IFN-and TNF-in the colons, compared with those receiving EC-DC-derived T cells ( Figure  8e ). In all groups of mice, we could not detect any significant difference in IL-6 production (data not shown). These data suggest that EC-DCs are able to effectively induce the generation of colitis-protective T reg cells.
DISCUSSION
It is becoming increasingly clear that immune cells isolated from mucosal tissues exhibit very peculiar phenotypes. 8 Macrophages, for instance, display bactericidal activity without inducing inflammation, 15 drive the development of T reg cells, and control DC function. 16 DCs isolated from either Peyer ' s patches or the LP are also noninflammatory, 8, 17, 12, 18, 19, 35 and a subtype of MLN-DCs expressing CD103 is involved in T-cell-mediated regulation of experimental colitis. 14 CD103 + DCs impart guthoming properties to T cells 20 and drive the development of T reg cells by a RA-and TGF--dependent mechanism. 9,10 
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All this evidence strongly supports the notion that gut DCs confer " mucosal " properties to effector immune cells, but still very little is known on what drives the " mucosal " phenotype of the DCs. Our results emphasize the role of the microenvironment, and in particular of intestinal ECs, in the control of DC function by driving the development of " tolerogenic mucosal " DCs. EC-DCs released higher amounts of IL-2 and IL-10 in response to LPS when compared with non-conditioned DCs, and drove the de novo generation of CD4 + CD25 + Foxp3 + T reg cells, which were suppressive. In agreement with an involvement of the mucosal environment, spleen DCs incubated with EC supernatant displayed increased ability to generate de novo T reg cells, which was similar to that of MLN-DCs. The ability of DCs to drive T reg cells correlated with a decreased production of IL-12 and IL-23, and a reduced ability to drive Th1 and Th17 development. Furthermore, DCs in close proximity with ECs upregulated the expression of CD103, a marker that characterizes MLN tolerogenic DCs coming from mucosal sites. 20 When FACS-sorted, primarily the CD103 + EC-DCs displayed tolerogenic properties and upregulated 4 7, confirming that CD103 is a marker of gut-derived tolerogenic DCs and that the interaction with ECs confers full mucosal properties to DCs. Despite an increase in CD103 + cells and the induction of aldh1a2 after EC contact, the number of converted Foxp3 + T cells was similar to that obtained after simple supernatant conditioning, suggesting that the contact-dependent interaction might also confer different properties. It is possible that CD103 + DCs might play a role in IgA class switching, as RA has been shown to play a fundamental role in driving IgA development 21 and that mouse LP-DCs express higher levels of aldh1a2 and are involved in IgA class switching. 22 -24 Our data would support the notion that MLN CD103 + DCs could migrate from the LP, where they had received signals from the local environment, resulting in an inhibited inflammatory potential, the upregulation of CD103 after contact with Ecs, and the ability to induce T reg cells. The finding that aldh1a2 is upregulated after EC contact and is expressed by MLN CD103 + cells supports this hypothesis. Thus, we describe that ECs are conductors of DC function and disrupting this balance could result in inflammatory disorders.
What are the factors involved in generating tolerogenic DCs? We found that EC-derived TGF-and RA are necessary to drive the tolerogenic phenotype of DCs, because neutralization of either one was sufficient to affect the differentiation of T reg cells. However, TGF-alone is not sufficient to drive tolerogenic DCs as cell lines such as NIH-3T3 or 4T1 that are producing it even at higher levels than MODE-K cells still were unable to drive tolerogenic DCs at the same frequency. This is likely because of the reduced expression of the RA-converting enzyme 5 by 4T1 and NIH-3T3 cells, as RA signaling synergizes with TGF-to favor T reg -cell conversion. 9, 10 We could detect an upregulation of aldh1a2 in DCs after EC contact, but not after incubation with EC supernatant, suggesting that EC-derived RA is sufficient for the polarization of T reg -promoting DCs. In agreement with recently published reports, 25, 26 EC-derived RA was also involved in inhibiting Th17 responses as suppression of RA signaling restored IL-17 production in EC-DC / T-cell cocultures. It is likely that in proximity to ECs, RA is present at higher concentrations and hence inhibits Th17 induction. By contrast at a greater distance from ECs, the RA concentration might decrease and it has been shown that low levels of RA favor Th17 induction. 22 In addition, a subset of LP-DCs that expresses CD70 (CD11c low CD70 high ) and a unique series of ATP receptors was shown to respond to bacteria-derived ATP and to favor the development of Th17 cells. 27, 28 This suggests that CD103 + and CD70 + DC subsets may respond to the local microenvironmet differently according to their surface receptors and exert diverse activities. Finally, TSLP, which is produced by Intestinal epithelial cells, was not involved in the induction of tolerogenic DCs in mice, as DCs isolated from MLNs of TSLPR − / − mice displayed a phenotype similar to WT MLN-DCs. It is likely that EC-derived TSLP primarily plays a role in Th1 / Th2 control in the mouse system, as described previously by Zaph et al. 29 T reg cells play a major role in the immune homeostasis of the gut: adoptive transfer of antigen-experienced T cells, includ- 
ing T reg cells, can protect against experimental colitis. 30,31 MLN CD103 + DCs are involved in T-cell-mediated regulation of experimental colitis 14 presumably by the generation of T reg cells. However, the functionality of mucosally derived adaptive T reg cells has not been tested previously. As EC-DCs display properties very similar to mucosal tolerogenic DCs, we used them to generate T reg cells ex vivo to study their function during experimental colitis. We show that ex vivo EC-DCs generated a greater number of T reg cells, which were effective suppressors of T-cell proliferation in vitro and extremely potent in protecting against colitis in vivo . T reg cells were found to be generated by EC-DCs twofold above the rate observed using non-conditioned DCs, and although the physiological consequence of this difference cannot be predicted, still the observed effect was clear and consistently striking. This could be because of an increased suppressor activity (as shown in Figure 1f ), a higher frequency, or a greater gut-homing ability of EC-DC-generated T reg cells. Indeed, we describe that EC-CD103 + DCs upregulated the expression of the gut-homing marker, 4 7, on T reg cells, thus suggesting that not only can EC-DCs drive T reg -cell development but they can also imprint them with gut-homing properties, similar to gut DCs. 26 In conclusion, we describe that ECs play a major role in controlling DC function by conferring upon them a tolerogenic " mucosal " phenotype. EC-DCs can induce the development of gut-homing T reg cells with potent suppressor activity that protect against experimental colitis. This could open new avenues for possible therapeutic intervention. For instance, in a hypothetical treatment of inflammatory bowel disease, the use of gut-derived DCs for the generation of T reg cells is not feasible because of their paucity and difficulty of isolation. Thus, we propose a new therapeutic tool of imprinting ex vivo a " mucosal " tolerogenic phenotype to DCs for the development of gut-homing T reg cells. Our approach could offer a valid alternative to standard anti-inflammatory therapies that could revolutionize the treatment of inflammatory bowel disease.
METHODS
Mice
Female C57BL6J mice or BALB / c mice (6 -7 weeks old) were purchased from Charles River, Milan, Italy. DO11.10 BALB / c and DO11.10 SCID 
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TCR transgenic mice were maintained in microisolator cages in our specific pathogen-free animal facility. TSLPR − / − mice on C57 / BL6J background were kindly provided by Dr Warren J Leonard 32 and OT-II mice were purchased from Charles River. Foxp3-eGFP reporter mice were provided by M Oukka (Brigham and Women ' s Hospital, Cambridge, MA) 33 and were kindly provided by Dr Yasmine Belkaid (NIH). Animals were bred and maintained in our conventional animal facility. All experiments were carried out in accordance with the guidelines established in the Principles of Laboratory Animal Care (directive 86 / 609 / EEC).
DC cultures and EC isolation
BMDCs were generated from the bone marrows of C57 / BL6J, BALB / c, or TSLPR − / − mice, cultured in Iscove ' s modified Dulbecco ' s medium supplemented with 10 % fetal bovine serum, 2 mmol l − 1 glutamine, 100 IU ml − 1 penicillin, 100 g ml − 1 streptomycin, 50 mol l − 1 were collected on day 12 and were incubated in triplicate for 24 h in RPMI. Cytokine production in the supernatants was measured by ELISA. Data are representative of two experiments. Error bars, s.d. * P < 0.05. BMDC, bone marrow-derived DC; DSS, dextran sulfate sodium; EC-DC, EC-conditioned DCs; FACS, fluorescence-activated cell sorting; PBS, phosphate buffered saline; T reg , regulatory T cells.
